📷 Image: Wikimedia Commons / Jorge Royan
Health
Maharashtra FDA Cracks Down on Drug Manufacturing: 29 Licenses Cancelled, 71 Suspended
✍️ Mid-Day
🗓 25 Oct 2026, 01:47 AM
👁 19
The Maharashtra Food and Drug Administration (FDA) has taken stringent action against substandard drug manufacturing practices. Following 937 inspections, 29 drug licenses have been cancelled and 71 suspended.
The Maharashtra FDA conducted a comprehensive inspection drive across the state, focusing on drug manufacturing units. The inspections revealed serious violations of manufacturing standards and quality control measures, leading to the cancellation and suspension of licenses. The FDA emphasized the importance of adhering to stringent regulations to ensure the safety and efficacy of medicines available to the public.